Pindolol
- Generic Name
- Pindolol
- Brand Names
- Viskazide, Visken
- Drug Type
- Small Molecule
- Chemical Formula
- C14H20N2O2
- CAS Number
- 13523-86-9
- Unique Ingredient Identifier
- BJ4HF6IU1D
Overview
Pindolol is a first generation non-selective beta blocker used in the treatment of hypertension. Early research into the use of pindolol found it had chronotropic effects, and so further investigation focused on the treatment of arrhythmia. Research into pindolol's use in the treatment of hypertension began in the early 1970s. Pindolol was granted FDA approval on 3 September 1982.
Background
Pindolol is a first generation non-selective beta blocker used in the treatment of hypertension. Early research into the use of pindolol found it had chronotropic effects, and so further investigation focused on the treatment of arrhythmia. Research into pindolol's use in the treatment of hypertension began in the early 1970s. Pindolol was granted FDA approval on 3 September 1982.
Indication
Pindolol is indicated in the management of hypertension. In Canada, it is also indicated in the prophylaxis of angina.
Associated Conditions
- Angina Pectoris
- Atrial Fibrillation
- Depression
- Hypertension
Clinical Trials
FDA Approved Products
Singapore Approved Products
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.